In Editorial, The New England Journal of Medicine Calls Science Corporation's PRIMA Implant "The First Treatment to Restore Vision" In Patients Suffering From Advanced Geographic Atrophy Due to ...

UGX-202 is a novel, one-time intravitreally-delivered gene therapy that employs optogenetics with the aim to restore vision in people with retinal degeneration UGX-202 is currently being studied in ...

Scientists claim to have found a way to restore vision in people with a common developmental eye disorder by “rebooting” the retina to its early state, enabling it to grow and cure itself. Researchers ...

People with severe vision loss have been able to read again, thanks to a tiny wireless chip implanted in one of their eyes and a pair of high-tech glasses. Age-related macular degeneration (AMD) is a ...

A groundbreaking study published in The New England Journal of Medicine (NEJM) on Monday demonstrates how specialized devices using artificial intelligence can help restore central vision to treat ...